Home » Topics » Briefs » Other news to note

Other news to note
RSS

Highlights of Chugai's second quarter of 2011

Aug. 1, 2011

Nippon Chemiphar discontinues development of cathepsin K inhibitor licensed to Velcura

Aug. 1, 2011

Shionogi & Co. enters agreement to acquire C&O Pharmaceutical Technology

Aug. 1, 2011

Johnson & Johnson profiles highlights of second quarter 2011

July 26, 2011

Abbott updates progress of second quarter 2011

July 26, 2011

Bristol-Myers Squibb to acquire Amira Pharmaceuticals

July 22, 2011

Merck & Co. and Simcere sign agreement to establish joint venture in China

July 22, 2011

SuperGen acquires Astex Therapeutics

July 21, 2011

AMAG Pharmaceuticals and Allos Therapeutics advance plans to merge

July 21, 2011

Pfizer signs agreement to acquire Icagen

July 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...